Create
Query
event_store.db
—
signals
actions
agent_runs
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
intel_memory
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_0851d5e941ed in signals
id
sig_0851d5e941ed
Primary key.
TEXT
event_id
129354
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_sec_filing_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1819133/0001193125-26-160320.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1819133/0001193125-26-160320.txt","company":"Tango Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1819133/0001193125-26-160320.txt","article_chars":2343,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_6fccdcdf9df8b68a","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1819133/0001193125-26-160320.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:29:20.892607+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"DEFA14A","final_url":"https://www.sec.gov/Archives/edgar/data/1819133/0001193125-26-160320.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1819133/0001193125-26-160320.txt","source_event_id":"evt_edf027d0d1e6","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"a1ffece8e7ceb19a","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","June 4, 2026","May 21, 2026"],"entities":[{"asset_class":"equity","name":"Tango Therapeutics, Inc.","relevance":"high","symbol":"","type":"issuer"}],"event_type":"listing","information_gaps":["The specific purpose of the DEFA14A (e.g., whether it is definitive additional materials or other category) is not fully specified in the provided text beyond the cover-page checkboxes.","The actual proposal descriptions for items 1a/1b/1c are not included in the provided excerpt\u2014only the \u201cFor\u201d indications are shown.","No financial guidance or financial implications are disclosed in the provided text.","The \u201cAmendment No.\u201d field is blank in the excerpt, so the amendment sequence is unknown.","No prior known state is provided in the prompt, so the \u201cwhat changed vs prior state\u201d cannot be determined from the given information."],"key_facts":["The document is a Schedule 14A proxy statement (proxy materials).","Form type is DEFA14A.","The filing indicates it is for a shareholder meeting to be held on June 4, 2026.","The notice states shareholders can view the proxy statement and annual report online at www.ProxyVote.com or request free paper/email copies.","The notice includes a request deadline of May 21, 2026 for receiving paper/email copies.","The text shows voting recommendations/positions labeled \u201cBoard Recommends\u201d with items 1a, 1b, and 1c marked \u201cFor\u201d (as displayed in the overview).","The filing includes standard proxy statement cover-page checkboxes (e.g., definitive proxy statement/additional materials) but the specific amendment number is shown as blank (\u201cAmendment No. \u201d)."],"numeric_claims":[{"label":"Shareholder meeting date","value":"June 4, 2026"},{"label":"Copy request deadline","value":"May 21, 2026"}],"primary_claim":"Tango Therapeutics, Inc. filed Form DEFA14A (Schedule 14A proxy statement) on 2026-04-17/18, with shareholder meeting materials for a meeting to be held on June 4, 2026.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Tango Therapeutics, Inc. filed a Schedule 14A proxy statement on Form DEFA14A. The filing provides notice/overview of proposals for a shareholder meeting scheduled for June 4, 2026.","topics":["SEC filing","proxy statement","Schedule 14A","shareholder meeting notice","voting proposals"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 Tango Therapeutics, Inc. \u00b7 Filed 20260417","ticker":"TNGX","tickers":["TNGX"],"title":"TNGX filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1819133/0001193125-26-160320.txt"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_sec_filings
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_edf027d0d1e6"]}
TEXT
dedupe_key
signal_enriched:discovery_sec_filing_delta:1f19740ad8532d68
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-18T03:05:05.644967+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel